Roundup Non-Hodgkin’s Lymphoma Lawsuit Overview
Tens of thousands of people have filed lawsuits against the manufacturer of the world’s most popular weedkiller, Roundup. Legal documents allege that the manufacturer knew or should have known that exposure to the herbicide’s active ingredient, chemical glyphosate, has been linked to an increased risk of non-Hodgkin’s lymphoma.
Many cases have been consolidated into an ongoing multidistrict litigation (In re: Roundup Products Liability Litigation (MDL No. 2741). Individuals who have been diagnosed with non-Hodgkin’s lymphoma after being exposed to Roundup may still be able to take legal action and are encouraged to contact an experienced attorney for a free consultation.
Roundup and Non-Hodgkin’s Lymphoma Lawsuit – 2025 Updates
July 2024: Over 4,000 Roundup lawsuits remain in the MDL filed in the Northern District of California. The number of cases continues to grow, although at a slower rate due to many cases being heard in state courts.
June 2024: A judge reduced the $2.2 billion award in the McKivison case to $400 million, arguing that the initial amount was excessive.
April 2024: To date, 4,281 cases are pending in the Roundup MDL in the Northern District of California. Individuals who have been diagnosed with non-Hodgkin lymphoma after being exposed to Roundup may still be eligible to take legal action against the manufacturer.
March 2024: A Pennsylvania jury finds in favor of Bayer in the Kline v. Monsanto case. This marks the first win in Philadelphia in a Roundup case. Attorneys for the plaintiff in the case argued that the court excluded critical pieces of evidence. Bayer announces it is working on an alternative to glyphosate. The company believes the glyphosate alternative will be available to consumers by 2028.
February 2024: An additional two dozen cases are added to the MDL in California. Cases are also filed around the country and are being heard in state courts. In one case (Kline v. Monsanto), a retired U.S. postal worker alleged that his cancer was caused by the use of Roundup. The trial for the case started in the Philadelphia Court of Common Pleas.
January 2024: A Pennsylvania jury awarded $2.2 billion to a plaintiff who had developed non-Hodgkin lymphoma after being exposed to Roundup. John McKivison, a 49-year-old landscaper, was awarded $250 million in compensatory damages and $2 billion in punitive damages.
About the Roundup Non-Hodgkin’s Lymphoma Lawsuit:
What Is Non-Hodgkin’s Lymphoma From Roundup?
How Does Roundup Cause Non-Hodgkin’s Lymphoma?
Studies Show Roundup Linked to Non-Hodgkin’s Lymphoma
Regulations on Roundup Triggered by Non-Hodgkin’s Lymphoma Concerns
Symptoms of Non-Hodgkin’s Lymphoma From Roundup
What Type of Non-Hodgkin’s Lymphoma Is Caused By Roundup?
Does Roundup Cause Non-Hodgkin’s Lymphoma With Occasional Use?
How Much Roundup Does It Take to Get Non-Hodgkin’s Lymphoma?
Occupations With High Exposure to Roundup
Evidence Proving Roundup Caused Your Non-Hodgkin’s Lymphoma
Eligibility Criteria for a Roundup Non-Hodgkin’s Lymphoma Lawsuit
How to File a Roundup Non-Hodgkin’s Lymphoma Lawsuit
Statute of Limitations for a Roundup Non-Hodgkin’s Lymphoma Lawsuit
Roundup Settlement Amounts for Non-Hodgkin’s Lymphoma
What Is Non-Hodgkin’s Lymphoma From Roundup?
Non-Hodgkin’s lymphoma is a form of cancer that originates in the lymphatic system. The lymphatic system is part of the immune system, which protects a person from germs and disease. The cancer is defined by an abnormal growth of the lymphocytes or white blood cells.
Common symptoms of non-Hodgkin’s lymphoma:
- Swollen lymph nodes
- Fever
- Fatigue
- Night sweats
- Weight loss
Roundup is one of the world’s most commonly used herbicides. It was initially developed by Monsanto but is now owned by pharmaceutical and biotechnology giant Bayer AG. The active ingredient in Roundup is glyphosate. In 2015, the International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans.” Additionally, several studies and lawsuits allege that exposure to glyphosate may result in an increased risk for the development of non-Hodgkin’s lymphoma. Despite ongoing debate and divided scientific opinions about the matter, a 2021 study found exposure to glyphosate had a 41% risk of causing mutations in human chromosomes leading to non-Hodgkin’s lymphoma.
While the Environmental Protection Agency (EPA) concluded that glyphosate is not likely carcinogenic to humans at current exposure levels, several significant financial awards have been awarded to plaintiffs in lawsuits related to non-Hodgkin lymphoma caused by Roundup. Bayer agreed to set aside nearly $11 billion to settle these claims. It appears that the evidence indicating a link between glyphosate and non-Hodgkin’s lymphoma is increasing, prompting organizations like the World Health Organization (WHO) to label the chemical as likely carcinogenic.
How Does Roundup Cause Non-Hodgkin’s Lymphoma?
Multiple studies and regulatory agencies have found that exposure to the active ingredient in Roundup, glyphosate, may substantially increase a person’s risk of developing non-Hodgkin’s lymphoma. The exact mechanism by which Roundup might cause non-Hodgkin’s lymphoma is not fully understood and remains a topic of ongoing research and debate.
Proposed theories from scientific studies on how Roundup (glyphosate) may cause non-Hodgkin’s lymphoma:
DNA Damage
- Oxidative Stress: Glyphosate may cause oxidative stress, leading to the production of reactive oxygen species (ROS).
- DNA Mutations: These ROS can damage cellular DNA, potentially causing mutations that contribute to the development of cancer, including NHL.
Disruption of the Immune System
- Immune Function Interference: Some studies suggest glyphosate may interfere with the immune system’s functioning.
- Cancer Detection Impairment: This disruption could impair the body’s ability to detect and destroy cancerous cells, increasing the risk of NHL.
Endocrine Disruption
- Hormone Function Interference: Glyphosate is suspected of being an endocrine disruptor, which can interfere with hormone function.
- Regulation of Immune Cells: Hormonal imbalances can affect immune cell regulation, potentially leading to lymphomas.
Microbiome Impact
- Gut Microbiome Alteration: Emerging research suggests glyphosate might alter the human gut microbiome.
- Immune Function Impact: Changes in the gut microbiome could lead to an increased risk of immune-related cancers like NHL.
Inflammatory Pathways
- Chronic Inflammation: Glyphosate exposure might trigger chronic inflammation, a known risk factor for many types of cancer.
- Malignant Cell Environment: Persistent inflammation can create an environment that supports the growth and survival of malignant cells.
Studies Show Roundup Linked to Non-Hodgkin’s Lymphoma
While research is ongoing as to why the active ingredient in Roundup, glyphosate, may increase a person’s risk of developing certain kinds of cancer, including non-Hodgkin’s lymphoma, several studies have indicated a link between the two.
Studies and regulatory reviews investigating the link between Roundup and non-Hodgkin’s lymphoma:
- International Agency for Research on Cancer (IARC) Monograph (2015): The IARC, a part of the World Health Organization (WHO), classified glyphosate as “probably carcinogenic to humans” (Group 2A) based on sufficient evidence of carcinogenicity in animals and limited evidence in humans. The findings highlighted studies showing a positive association between glyphosate exposure and an increased risk of non-Hodgkin’s lymphoma.
- Meta-Analysis by Zhang et al. (2019): According to this meta-analysis, high exposure to glyphosate-based herbicides is associated with a 41% increase in the risk of developing non-Hodgkin’s lymphoma. The meta-analysis reviewed six epidemiological studies, which ultimately led researchers to believe there was a compelling link between glyphosate exposure and non-Hodgkin’s lymphoma.
- Agricultural Health Study (AHS): The Agricultural Health Study is a large, ongoing prospective study of agricultural workers in the United States. While it initially found no significant association between glyphosate use and non-Hodgkin’s lymphoma (NHL), subsequent analyses suggested a potential increased risk among individuals with high exposure to the chemical.
- Eriksson et al. (2008): The case-control study found that individuals with more than 10 days of glyphosate use per year had a significantly higher risk of NHL compared to non-users.
- McDuffie et al. (2001): The cross-Canada study of pesticides and health reported an increased risk of NHL among individuals exposed to glyphosate.
- Schinasi and Leon (2014): The meta-analysis investigated the association between glyphosate and NHL, reporting mixed findings but suggesting a potential increased risk of NHL with higher levels of glyphosate exposure.
- Chang and Delzell (2016): The meta-analysis conducted a systematic review of studies investigating the relationship between glyphosate exposure and the risk of lymphohematopoietic cancer. The findings were mixed but generally pointed towards an increased risk of NHL with higher glyphosate exposure.
In addition to these studies, the Environmental Protection Agency (EPA) continues to investigate the relationship between glyphosate and cancer. Thus far, the regulatory agency has generally concluded that glyphosate is not likely to be carcinogenic to humans at current exposure levels.
However, some scientists and advocacy groups argue that the EPA did not adequately account for certain epidemiological studies linking glyphosate to NHL.
Regulations on Roundup Triggered by Non-Hodgkin’s Lymphoma Concerns
As concerns grow over the potential link between Roundup’s active ingredient, glyphosate, and an increased risk of developing non-Hodgkin’s lymphoma, many state and federal agencies have taken steps to reduce or eliminate the use of the chemical. At the federal level, the EPA updated its labeling requirements to ensure safe use and reduce the risk to non-target wildlife.
State-level actions and regulations:
- California: In 2017, glyphosate was added to California’s Proposition 65 list, which contains chemicals known to cause cancer. Products containing glyphosate must now carry a warning label. Additionally, several cities and counties have banned or restricted the use of glyphosate in public places, such as parks, schools, and municipal properties.
- New York: The State of New York has taken extensive action to limit or stop the use of glyphosate on public lands. In 2021, the state banned the chemical on state-owned or managed properties, and the City of New York took similar actions that same year.
- Hawaii: Counties within Hawaii, including Maui and Hawaii, have restricted or banned the use of glyphosate and other pesticides in public spaces and near schools.
- Maryland: Montgomery County banned the use of glyphosate on lawns, playgrounds, and other public spaces in the area. While the ban initially faced legal challenges, the State Supreme Court eventually upheld the ban, prompting some cities (such as Rockville) to follow suit.
- Oregon: Cities throughout the State, including Portland, have banned the use of certain synthetic pesticides, including glyphosate, on city-owned properties.
- Massachusetts: Municipalities including Marblehead and South Portland have adopted policies to reduce or eliminate the use of glyphosate on town-owned lands.
In addition to these state and federal regulations, many cities, towns, and municipalities have taken steps to ban or reduce the use of glyphosate on publicly owned lands, particularly near schools and childcare facilities.
Types of Roundup Exposure
Multiple studies have shown a higher incidence of non-Hodgkin’s lymphoma (NHL) in individuals with common exposure to glyphosate, the active ingredient in Roundup. Prolonged exposure, such as that experienced by individuals in the agricultural industry, landscapers, and farmers tend to be at a higher risk for developing the disease.
Types of Roundup exposure:
- Inhalation: Involves breathing in spray mist or dust particles containing glyphosate. It generally occurs during the application of Roundup or as a result of being near areas where it is being applied.
- Dermal Contact: Involves getting Roundup on the skin during mixing, loading, or applying the herbicide. It may also happen as a result of contact with treated plants and soil.
- Ingestion: Involves the accidental swallowing of Roundup. It can also happen if hands are not washed properly after handling or through contaminated food or water.
- Eye Contact: Involves getting Roundup in the eyes through splashes or by touching eyes with contaminated hands.
- Environmental Residue: Involves indirect exposure by coming into contact with surfaces, plants, or soil treated with Roundup.
Symptoms of Non-Hodgkin’s Lymphoma From Roundup
The symptoms of non-Hodgkin’s lymphoma by exposure to Roundup (glyphosate) are generally the same regardless of the cause. If you have been exposed to Roundup and begin to suffer adverse health conditions, it is imperative to speak with an attorney as soon as possible. You may be able to take legal action.
Common Symptoms of Non-Hodgkin’s Lymphoma (NHL):
- Swollen lymph nodes
- Painless swelling of lymph nodes in the neck, armpits, or groin
- Unexplained fever
- Drenching night sweats
- Unintended weight loss (more than 10% of body weight)
- Fatigue
- Persistent feelings of tiredness or lack of energy
- Breathing difficulties
- Shortness of breath
- Chest pain or pressure
- Swelling or pain in the abdomen
- A feeling of fullness after eating only a small amount (due to the enlarged spleen or lymph nodes)
- Itchy skin
- Severe itching without an obvious cause.
- Persistent cough or hoarseness
- Changes in the voice
- Frequent infections
- Neurological symptoms
- Headaches
- Cognitive or personality changes
- Seizures
Anyone experiencing these symptoms with known exposure to glyphosate should seek medical evaluation for a proper diagnosis and prompt treatment. It is also recommended to speak with an attorney about potential compensation.
What Type of Non-Hodgkin’s Lymphoma Is Caused By Roundup?
While there is no specific type of non-Hodgkin’s lymphoma (NHL) definitively proven to be caused by Roundup (glyphosate), several studies and legal cases have explored potential links.
Commonly investigated types of NHL:
- Diffuse Large B-cell lymphoma (DLBCL)
- Primary Mediastinal B-cell Lymphoma
- Follicular Lymphoma
- Chronic Lymphocytic Leukemia (CLL)
- Small lymphocytic lymphoma (SLL)
Evidence continues to mount that glyphosate is carcinogenic to humans and linked to NHLs, mostly DLBCL.
Does Roundup Cause Non-Hodgkin’s Lymphoma With Occasional Use?
Many studies indicate that prolonged exposure to glyphosate (Roundup) can increase a person’s risk of developing non-Hodgkin’s lymphoma; however, a pathologist has now testified that using the chemical more than two days per year doubles a person’s risk.
Dr. Dennis Weisenburger, a pathologist who testified in multiple Roundup lawsuits, attributed a couple’s aggressive form of cancer to their intense spraying of the pesticide. The expert also noted that it was not the length of exposure but rather the intensity that increases a person’s risk of developing cancer. For instance, the number of days of exposure is more significant than the number of years the chemical was used.
How Much Roundup Does It Take to Get Non-Hodgkin’s Lymphoma?
The exact amount of glyphosate exposure needed to cause non-Hodgkin’s lymphoma has not been established because of the complexity of cancer development and variability in individual susceptibility; however, there are influencing risk factors.
Factors influencing a person’s risk of developing non-Hodgkin’s lymphoma related to glyphosate exposure:
- Level and frequency of exposure
- Duration of exposure
- Individual susceptibility
- Genetic factors
- Overall health
- Concurrent exposure to other chemicals
- Environmental factors
It is believed that certain occupations make an individual more susceptible to developing non-Hodgkin’s lymphoma because of the level and frequency of exposure to glyphosate.
Occupations With High Exposure to Roundup
Workers in occupations that require direct exposure to pesticides tend to have the highest risk of developing non-Hodgkin’s lymphoma.
Occupations with high exposure to glyphosate (Roundup):
- Farmers and Agricultural Workers: Often experience direct exposure when mixing and loading concentrated glyphosate formulations, spraying glyphosate on crops and fields using backpack sprayers, hand-held equipment, or tractor-mounted sprayers, handling treated crops and working in recently treated fields, or cleaning and maintaining spraying equipment.
- Landscapers and Groundskeepers: May experience direct exposure when applying glyphosate to control weeds in gardens, lawns, parks, and other landscaped areas, using backpack sprayers or hand-held equipment for spot treatments, or working in areas shortly after glyphosate has been applied.
- Forestry Workers: May be at risk for direct exposure when applying glyphosate to manage underbrush and unwanted vegetation in forests, or using backpack sprayers, hand-held equipment, or aerial spraying techniques.
- Horticulturists and Nursery Workers: Direct exposure frequently occurs when applying glyphosate to control weeds in nurseries and greenhouses or handling treated plants and working in treated areas.
- Public Works Employees: May be at risk for direct exposure when using glyphosate to manage vegetation along roadsides, highways, and public properties or applying glyphosate to control invasive species and maintain clear right-of-ways.
- Golf Course Maintenance Workers: Direct exposure may occur when applying glyphosate to manage weeds on fairways, greens, and rough areas or when spraying equipment is used to handle treated areas.
- Pesticide Applicators: Direct exposure generally happens to professional applicators who apply glyphosate for various clients, including agricultural, residential, and commercial properties or during the mixing, loading, and applying glyphosate using various types of spraying equipment.
- Research Scientists and Laboratory Technicians: May be at risk for direct exposure during handling glyphosate during experimental applications and studies or while mixing and preparing glyphosate solutions.
Evidence Proving Roundup Caused Your Non-Hodgkin’s Lymphoma
It can be challenging to prove Roundup caused your non-Hodgkin’s lymphoma without the help of an experienced attorney and substantial evidence.
Evidence that can help substantiate your claim:
Medical Records
- Proof of diagnosis
- Pathology reports confirming non-Hodgkin’s lymphoma
- Medical records documenting symptoms, treatments, and progression
- Detailed health history, including other risk factors for NHL
- Family medical history of similar diagnoses
- Doctor’s notes and hospital discharge summaries
- Biopsy reports and pathology results
- Treatment plans and diagnostic imaging results
- Records of chemotherapy and radiation therapy sessions
Personal and Employment Records
- Employment records or work schedules showing job duties and frequency of Roundup use
- Logs of specific dates and times of Roundup application
- Testimonies from co-workers or supervisors confirming Roundup exposure
- Diaries or records detailing the frequency and manner of Roundup use
- Job titles and descriptions involving Roundup use
- Employment contracts specifying herbicide application tasks
- Maintenance logs and incident reports
- Training records and personal logs
- Photographs or videos of Roundup use in the work environment
Proof of Purchase
- Store receipts for Roundup
- Credit card or bank statements showing purchases
- Invoices from suppliers or landscaping companies using Roundup
- Clear, dated photographs of empty and partially filled Roundup containers
- Labels and records of purchase date, location, and use frequency
- Witness statements and notes on container condition
Landscaping Contracts
- Service agreements detailing Roundup use
- Billing statements and work orders for herbicide application
- Maintenance logs and annual service contracts
- Property management agreements specifying Roundup use
Proof of Loss of Income
- Pay stubs showing reduced hours or termination
- Tax returns indicating income drop
- Employer letters confirming work capacity reduction or job loss
- Bank statements reflecting income changes
- Documentation of disability benefits or unemployment claims
- Statements from financial advisors detailing income loss
Eligibility Criteria for a Roundup Non-Hodgkin’s Lymphoma Lawsuit
Successful Roundup non-Hodgkin’s lymphoma cases must meet certain eligibility requirements, including proof of exposure and diagnosis of non-Hodgkin’s lymphoma or another qualifying cancer. To determine if you are eligible for a lawsuit, it is strongly recommended that you speak to an attorney.
Eligibility Criteria for Filing a Roundup Cancer Lawsuit:
- Proof of exposure: Successful claimants will be able to show that they sustained direct exposure to Roundup, had long-term exposure to the substance, and had used Roundup at least two years before their diagnosis or been exposed to Roundup or glyphosate more than 10 times since 1974.
- Proof of diagnosis: Individuals must have been diagnosed with non-Hodgkin lymphoma or another qualifying cancer on or after June 1, 2018.
Qualifying cancers:
- Hairy Cell Leukemia
- Small Lymphocytic Leukemia
- T-Cell Leukemia
- B-Cell Lymphoma
- Burkitt Lymphoma
- Chronic Lymphocytic Leukemia
- Follicular Lymphoma
- Lymphoblastic Lymphoma
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
- Non-Hodgkin’s Lymphoma
- T-Cell Lymphoma
It is imperative to ensure that the statute of limitations has not passed. Statutes of limitation are state-specific and may be affected by the date of diagnosis. An attorney can help you determine whether you qualify. It is important to note that you must have received treatment for non-Hodgkin lymphoma or another type of cancer. Loved ones of individuals who have died from Roundup exposure may also qualify.
How to File a Roundup Non-Hodgkin’s Lymphoma Lawsuit
There are several steps to take in order to file a Roundup non-Hodgkin’s lymphoma lawsuit. An experienced attorney can help ensure that your case is successfully filed in the appropriate courthouse and that it meets all legal requirements.
Steps to file a Roundup non-Hodgkin’s lymphoma lawsuit:
Step 1: Confirm Eligibility
- Cancer Diagnosis: Ensure you have a diagnosis of non-Hodgkin’s lymphoma or other cancers linked to glyphosate exposure.
- Exposure Verification: Collect proof of your exposure to Roundup, such as purchase receipts, usage logs, or testimony from witnesses who observed your use of the product.
Step 2: Consult a Specialized Lawyer
- Find a Lawyer: Look for attorneys specializing in toxic exposure or product liability, particularly those with experience in Roundup cases.
- Free Case Evaluation: Many law firms offer free consultations to assess the viability of your claim.
Step 3: Gather and Prepare Necessary Documentation
- Medical Records: Collect all relevant medical documentation that confirms your diagnosis and outlines your treatment.
- Proof of Exposure: Gather any tangible evidence of Roundup use, such as purchase receipts or containers, and document your usage patterns.
- Witness Statements: Compile statements from co-workers, family members, or friends who can corroborate your Roundup exposure.
Step 4: File the Lawsuit
- Official Filing: Your attorney will prepare and file a legal complaint against Monsanto (Bayer), the manufacturer of Roundup, in the appropriate court.
- Statute of Limitations: Ensure the lawsuit is filed within the legal time limits, which vary by state but typically range from one to six years from the date of diagnosis or discovery of the cancer link.
Step 5: Discovery Phase
- Exchange of Evidence: Both sides will exchange information and evidence. This includes depositions, requests for documents, and interrogatories.
- Expert Testimonies: Both parties may hire experts to testify on the carcinogenic nature of glyphosate and its impact on your health.
Step 6: Settlement Negotiations
- Negotiation Process: Before going to trial, there is often an attempt to settle the case out of court. Your lawyer will negotiate with Bayer’s representatives to reach a compensation amount that covers your damages.
- Consider Settlement Offers: Evaluate all settlement offers with your attorney to determine if they adequately cover your medical costs, lost income, pain and suffering, and other damages.
Step 7: Trial
- Going to Court: If a settlement is not reached, your case may go to trial where your attorney will present your case in front of a judge or jury.
- Presentation of Evidence: Both sides will present their evidence, and a verdict will be reached based on the merits of the case.
Step 8: Post-Trial
- Appeals Process: If the outcome of the trial is unfavorable, you have the option to appeal the decision.
- Collection of Damages: If the verdict is in your favor, steps will be taken to collect the awarded damages.
Step 9: Monitor Health and Follow-Up
- Ongoing Medical Care: Continue to monitor your health and follow up with appropriate medical care for your condition.
- Legal Follow-Ups: Stay in contact with your lawyer to handle any legal post-trial follow-ups or appeals.
Statute of Limitations for a Roundup Non-Hodgkin’s Lymphoma Lawsuit
In general, the statute of limitations for a Roundup Non-Hodgkin’s lymphoma lawsuit ranges from one to three years from the date of cancer diagnosis or death of your loved one. However, statutes are state-specific and may depend on a number of factors, including when the plaintiff discovers the link between their condition and the exposure to glyphosate (Roundup), known as the discovery rule.
Other factors that may influence the amount of time you have to file a lawsuit include when it became known to the public that Roundup could be harmful and whether any ongoing mass tort litigation paused the statute of limitations. It is important to note that due to the statute of repose in some states, if too much time has passed between the filing of the case and the exposure, an individual may be barred from taking legal action, regardless of the discovery date.
Roundup Settlement Amounts for Non-Hodgkin’s Lymphoma
Settlement amounts for Roundup non-Hodgkin’s lymphoma cases are expected to range between $5,000 and $250,000 or more. In the landmark June 2020 Global Settlement, Bayer agreed to set aside $11 billion to settle Roundup cases, including a reserve of $1.25 billion for future claims. The global settlement averaged over $150,000 per plaintiff.
Factors that may influence the settlement an individual receives include the strength of the case (i.e., stronger evidence), injury severity, ability to prove diagnosis and treatment, amount of damages sought, and duration and intensity of Roundup exposure. Settlements are often determined based on a scoring system that accounts for factors like age, health, and extent of exposure.
The average post-2020 settlement payout is expected to be $160,000. Despite the global settlement, there are still over 40,000 active cases in litigation. The quality of legal representation and the ability to prove Bayer’s negligence play critical roles in the outcome of settlements.
Contact a Roundup Non-Hodgkin’s Lymphoma Lawyer
Individuals who suffered prolonged exposure to Roundup and were subsequently diagnosed with non-Hodgkin’s lymphoma may be able to take legal action for their injuries. King Law is well-versed in handling product liability cases and holding negligent manufacturers accountable for putting dangerous or defective products on the market. With years of collective experience, the attorneys at King Law can help ensure you receive the compensation you deserve. Contact our office today to schedule a free consultation.